| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.08B | +23.3% |
| Cost of Revenue | $628.9M | +29.7% |
| Gross Profit | $453.7M | +15.3% |
| R&D Expense | $5.8M | +9.4% |
| SG&A Expense | $269.5M | +27.1% |
| Operating Income | $168.5M | -7.0% |
| Pre-tax Income | $145.6M | -19.2% |
| Income Tax | $32.7M | -23.3% |
| Net Income | $112.0M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.8M | -85.0% |
| Accounts Receivable | $210.3M | +35.1% |
| Inventory | $309.7M | +58.9% |
| Current Assets | $589.1M | -0.6% |
| Total Assets | $2.32B | +68.0% |
| Current Liabilities | $226.9M | +54.2% |
| Long-term Debt | $871.5M | +8.9% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $149.7M | -11.1% |
| Investing Cash Flow | -$1.04B | -920.4% |
| Financing Cash Flow | $701.5M | +408.1% |
| -18.0% |
| EPS (Basic) | $6.73 | -20.0% |
| EPS (Diluted) | $6.70 | -20.0% |
| Total Liabilities |
| $1.25B |
| +335.2% |
| Stockholders' Equity | $1.05B | -2.0% |